术前阿片类药物及其对全髋关节置换术后结局的剂量依赖性影响
本研究基于Humana理赔数据库2007—2020年数据,将术前3个月内有阿片类药物处方的初次全髋关节置换术患者按每日吗啡毫克当量(MME)分为5层,并与未使用阿片类药物的患者1:1匹配,比较急诊就诊、再入院及术后并发症。结果显示术前阿片类药物使用与剂量依赖性并发症增加相关,每日仅5毫克氢可酮即可显著增加急诊就诊和再入院风险。
要点
- 术前使用阿片类药物的患者90天内急诊就诊率为17.0%,未使用阿片类药物患者为13.3%(P < .001)。
- 术前使用阿片类药物的患者90天内再入院率为9.5%,未使用阿片类药物患者为7.4%(P < .001)。
- 第2至5层(每日5 MME及以上)术前使用阿片类药物的患者表浅感染、假体周围关节感染和脱位发生率增加;第3至5层(每日11 MME及以上)翻修手术风险增加。
核心结论
- 术前阿片类药物使用与全髋关节置换术后并发症的剂量依赖性增加相关。
- 每日仅5毫克氢可酮即可导致急诊就诊和再入院显著增加,更高剂量与脱位、表浅感染、假体周围关节感染和翻修手术相关。
- 仍需继续开展关于阿片类药物用于骨关节炎非手术治疗有害影响的教育。
研究设计与样本
- 基于Humana理赔数据库(2007—2020年)的回顾性研究,纳入术前3个月内有阿片类药物处方的初次全髋关节置换术患者。
- 按每日阿片类药物剂量分层:第1层<5 MME;第2层5-10 MME;第3层11-25 MME;第4层26-50 MME;第5层>50 MME。
- 每层与未使用阿片类药物的患者1:1匹配,共识别并匹配67,719例术前使用阿片类药物的患者。
- 比较急诊就诊、再入院和术后并发症。
- 证据等级为Level III。
主要发现
- 术前使用阿片类药物的患者90天内急诊就诊率为17.0%,未使用阿片类药物患者为13.3%(P < .001)。
- 术前使用阿片类药物的患者90天内再入院率为9.5%,未使用阿片类药物患者为7.4%(P < .001)。
- 按剂量分层后,所有层级的阿片类药物使用者急诊就诊和再入院风险均更高。
- 第2至5层术前使用阿片类药物的患者表浅感染、假体周围关节感染和脱位发生率增加。
- 第3至5层患者翻修手术风险增加。
关键数值与推荐
- 每日阿片类药物剂量分层阈值:第1层<5 MME;第2层5-10 MME;第3层11-25 MME;第4层26-50 MME;第5层>50 MME。
- 每日仅5毫克氢可酮即可导致急诊就诊和再入院显著增加。
- 第2至5层与表浅感染、假体周围关节感染和脱位发生率增加相关。
- 第3至5层与翻修手术风险增加相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study is to identify the preoperative daily opioid dose associated with increased complications after primary total hip arthroplasty (THA). METHODS: Primary THA patients in the Humana claims database (2007-2020) with an opioid prescription within 3 months prior to surgery were identified. Patients were stratified based on daily opioid dose: Tier 1, <5 milligram morphine equivalents (MME); Tier 2, 5-10 MME; Tier 3, 11-25 MME; Tier 4, 26-50 MME; Tier 5, >50 MME. Each tier was matched 1:1 to opioid-naïve patients. Emergency department (ED) visits, readmissions, and postoperative complications were compared. RESULTS: In total, 67,719 patients using preoperative opioids were identified and matched. 17.0% of patients using preoperative opioids visited the ED within 90 days, compared to 13.3% of opioid-naïve patients (P < .001). About 9.5% of patients using preoperative opioids were readmitted within 90 days, compared to 7.4% of opioid-naïve patients (P < .001). When stratified by tier, opioid users in all tiers had higher risk of ED visits and readmission. Rates of superficial infection, periprosthetic joint infection, and dislocation were increased in patients taking preoperative opioids in Tiers 2 through 5. Patients in Tiers 3 through 5 had an increased risk of revision surgery. CONCLUSION: Preoperative opioid use is associated with a dose-dependent increase in complications after THA. Just one 5 mg hydrocodone tablet daily leads to a significant increase in ED visits and readmission, while higher doses are associated with dislocation, superficial infection, periprosthetic joint infection, and revision surgery. Continued education regarding the harmful effects of opioids prescribed for the nonoperative treatment of osteoarthritis is still needed. LEVEL OF EVIDENCE: Level III.
引用
- Terhune EB, Hannon CP, Burnett RA, et al. Preoperative Opioids and the Dose-Dependent Effect on Outcomes After Total Hip Arthroplasty. J Arthroplasty. 2021. PMID: 34942347. doi:10.1016/j.arth.2021.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。